Article

251 views
A unicorn is a startup company with a current valuation of US$1 billion or more. In this post, Medgenera DATALABS has compiled data from 25 venture-backed private healthcare companies with post-money valuations of US $1 billion and more. Subscribe to read the full report.
Authentic, Ad-free Reporting
High-quality, Exclusive Content
Original Market Research Reports
Original Resources & Databases
Global Surveys & Guidelines
Lowest Subscription Pricing

Healthcare News You Won't Read Elsewhere

Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.

Access articles & resources worth up to $4000.

KEY POINTS A unicorn is a startup company with a current valuation of US$1 billion or more. Medgenera DATALABS has ...

You have read of your 8 free articles this month.

Subscribe to
Medgenera All-Access

Enjoy unlimited access to all contents, resources, exclusive market research reports, databases, surveys and many more features by subscribing to Medgenera All-Access.

Access articles & resources worth up to US $4, 000 per month.

Authentic, Ad-free Reporting
High-quality, Exclusive Content
Original Market Research Reports
Original Resources & Databases
Global Surveys & Guidelines
Lowest Subscription Pricing

Healthcare News You Won't Read Elsewhere

Most up-to-date information, original and in-depth reviews, full-length exclusive market reports and forecasts, full-access to the smart knowledge base centres, useful resources and databases.

Access articles & resources worth up to $4000.

More in MARKET INSIGHTS


MARKET INSIGHTS

9 Most Valuable Drugs Under Development (2018)

The top 9 drugs currently under research and developments are ranked based on their Net Present Value. These drugs are forecasted to be the future blockbuster. With $10,199 million Net Present Value, Aducanumab, the Ant-Alzheimer's investigational drug of Biogen is ranked as the topmost valued upcoming drug under development. Total Word Counts of the article: 782. Continue reading..

MARKET INSIGHTS

Billion Dollars Healthcare Startups (2018)

A unicorn is a startup company with a current valuation of US$1 billion or more. In this post, Medgenera DATALABS has compiled data from 25 venture-backed private healthcare companies with post-money valuations of US $1 billion and more. Subscribe to read the full report.

MARKET INSIGHTS

Bristol-Myers Squibb Rises High with the Star Performer ‘Opdivo’

Bristol-Myers Squibb’s (BMS) has shown stellar growth in its revenue (by 7 percent) in 2017. Besides the staggering growth in revenue, it has also achieved important milestones in oncology.

MARKET INSIGHTS

mRNA Therapy Startup Moderna Deck up its Value to $7 Billion

With the latest equity financing of US $500M, Moderna is now the most valued healthcare unicorn startup in the world. The company is enabling messenger RNA science to develop a new generation of transformative medicines for patients with their Core “Expression” Platform: messenger RNA Therapeutics (a trademark platform). It has at least 10 candidates in Phase 1 or later stages of the clinical trials.

Most Popular


GROW

7 New Ideas to Start a Healthcare Business in India (2018)

Healthcare in India is showing a gradual progress and there is an abundance of opportunity to create an evolving business by tackling the major challenges of the mass population. Herein, we are proposing the seven new healthcare business ideas in India in 2018 which are based on our observations of the current Indian market, its behavior, challenges, and opportunities.

MARKET INSIGHTS

9 Most Valuable Drugs Under Development (2018)

The top 9 drugs currently under research and developments are ranked based on their Net Present Value. These drugs are forecasted to be the future blockbuster. With $10,199 million Net Present Value, Aducanumab, the Ant-Alzheimer's investigational drug of Biogen is ranked as the topmost valued upcoming drug under development. Total Word Counts of the article: 782. Continue reading..